The Shaking Palsy of the Larynx-Potential Biomarker for Multiple System Atrophy: A Pilot Study and Literature Review.

FEES biomarker dysphagia irregular arytenoid cartilage movements laryngeal dysfunction multiple system atrophy pharyngeal dysfunction tremulous arytenoid movements

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2019
Historique:
received: 26 11 2018
accepted: 25 02 2019
entrez: 12 4 2019
pubmed: 12 4 2019
medline: 12 4 2019
Statut: epublish

Résumé

In its early stages multiple system atrophy (MSA), a neurodegenerative movement disorder, can be difficult to differentiate from idiopathic Parkinson's disease (PD), and emphasis has been put on identifying premotor symptoms to allow for its early identification. The occurrence of vegetative symptoms in addition to motor impairment, such as orthostatic hypotension and neurogenic bladder dysfunction, enable the clinical diagnosis in the advanced stages of the disease. Usually with further disease progression, laryngeal abnormalities become clinically evident and can manifest in laryngeal stridor due to impaired vocal fold motion, such as vocal fold abduction restriction, mostly referred to as vocal fold paresis, or paradoxical vocal fold adduction during inspiration. While the pathogenesis of laryngeal stridor is discussed controversially, its occurrence is clearly associated with reduced life expectancy. Before the clinical manifestation of laryngeal dysfunction however, abnormal vocal fold motion can already be seen in patients that might not yet fulfill the diagnostic criteria of MSA. In this article we summarize the current literature on pharyngolaryngeal findings in MSA and report preliminary findings from a pilot study investigating eight consecutive MSA patients. Patients showed varying speech abnormalities. Only 2/8 patients exhibited laryngeal stridor. However, during FEES, all patients presented with irregular arytenoid cartilages movements and vocal fold abduction restriction. 3/8 showed vocal fold fixation and 1/8 paradoxical vocal fold motion. All patients presented with oropharyngeal dysphagia, 5/8 with penetration or aspiration events. We suggest that specific abnormal vocal fold motion can help identifying MSA patients and may allow for delimiting this disorder from idiopathic PD. These findings therefore may serve as a novel clinical biomarker for MSA. Based on the available data and our preliminary clinical experience we developed a standardized easy-to-implement task-protocol to be performed during flexible endoscopic evaluation of swallowing (FEES) for detection of MSA-related pharyngolaryngeal movement disorders. Furthermore, we initiated a prospective study to evaluate the diagnostic utility of this protocol.

Identifiants

pubmed: 30972002
doi: 10.3389/fneur.2019.00241
pmc: PMC6443854
doi:

Types de publication

Journal Article

Langues

eng

Pagination

241

Références

Mov Disord. 2000 Jan;15(1):77-83
pubmed: 10634245
J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):434-40
pubmed: 10727478
Mov Disord. 2000 Jul;15(4):699-704
pubmed: 10928581
Am J Otolaryngol. 2000 Sep-Oct;21(5):344-8
pubmed: 11032303
Lancet. 2000 Oct 14;356(9238):1329-30
pubmed: 11073029
Arch Neurol. 2001 Feb;58(2):259-64
pubmed: 11176964
J Physiol. 2001 Oct 1;536(Pt 1):237-49
pubmed: 11579172
Neurology. 2002 Feb 26;58(4):649-52
pubmed: 11865150
Brain. 2002 May;125(Pt 5):1070-83
pubmed: 11960896
J Neurol Sci. 2002 May 15;197(1-2):37-43
pubmed: 11997064
Eur Neurol. 2003;49(3):154-9
pubmed: 12646759
J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):982-4
pubmed: 12810801
Ann Otol Rhinol Laryngol. 2003 Jul;112(7):630-6
pubmed: 12903684
Muscle Nerve. 1992 Oct;15(10):1213-5
pubmed: 1406782
Laryngoscope. 2004 Feb;114(2):372-5
pubmed: 14755221
Laryngoscope. 2004 Feb;114(2):376-80
pubmed: 14755222
Ann Otol Rhinol Laryngol. 2004 Apr;113(4):253-8
pubmed: 15112966
Neurology. 2004 Sep 14;63(5):930-2
pubmed: 15365155
Mov Disord. 2005 Apr;20(4):451-6
pubmed: 15593313
J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1739-41
pubmed: 15946984
Sleep Med. 2005 Jul;6(4):359-62
pubmed: 15978519
Otolaryngol Head Neck Surg. 2005 Nov;133(5):654-65
pubmed: 16274788
J Neural Transm (Vienna). 2005 Dec;112(12):1687-94
pubmed: 16284910
Auris Nasus Larynx. 2006 Sep;33(3):295-8
pubmed: 16406427
J Neurol Sci. 2006 Aug 15;247(1):53-8
pubmed: 16647088
Arch Neurol. 2006 Jul;63(7):978-81
pubmed: 16831967
J Neurol Neurosurg Psychiatry. 2007 Mar;78(3):327-9
pubmed: 17308296
Auris Nasus Larynx. 2007 Dec;34(4):443-52
pubmed: 17482397
Arch Neurol. 2007 Jun;64(6):856-61
pubmed: 17562934
Clin Neurol Neurosurg. 2007 Dec;109(10):892-5
pubmed: 17826894
Brain. 2008 May;131(Pt 5):1362-72
pubmed: 18385183
Mov Disord. 2008 Jun 15;23(8):1093-9
pubmed: 18442131
Ann Otol Rhinol Laryngol. 2008 May;117(5):317-26
pubmed: 18564527
Neurology. 2008 Aug 26;71(9):670-6
pubmed: 18725592
Dysphagia. 2009 Sep;24(3):333-48
pubmed: 19399555
Mov Disord. 2010 Jul 30;25(10):1418-23
pubmed: 20310045
Mov Disord. 2010 Jul 15;25(9):1239-45
pubmed: 20629130
Mov Disord. 2010 Nov 15;25(15):2604-12
pubmed: 20922810
Mov Disord. 2011 Apr;26(5):909-12
pubmed: 21287601
Lancet Neurol. 2012 Apr;11(4):361-8
pubmed: 22441197
J Voice. 2012 Nov;26(6):779-84
pubmed: 22721783
Mov Disord. 2012 Aug;27(9):1186-90
pubmed: 22806758
J Clin Sleep Med. 2012 Dec 15;8(6):713-5
pubmed: 23243406
Lancet Neurol. 2013 Mar;12(3):264-74
pubmed: 23391524
BMJ. 1990 Jun 2;300(6737):1441
pubmed: 2379004
Laryngoscope. 2014 Mar;124(3):730-5
pubmed: 24114946
Tremor Other Hyperkinet Mov (N Y). 2013 Sep 03;3:null
pubmed: 24116345
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
N Engl J Med. 2015 Jan 15;372(3):249-63
pubmed: 25587949
J Neurol. 2015;262(4):992-1001
pubmed: 25683763
Dysphagia. 2015 Dec;30(6):669-73
pubmed: 26205436
Brain. 2015 Dec;138(Pt 12):3623-31
pubmed: 26369944
Dysphagia. 2016 Feb;31(1):24-32
pubmed: 26590572
Eur Neurol. 2015;74(5-6):237-42
pubmed: 26618669
Parkinsonism Relat Disord. 2016 Mar;24:69-75
pubmed: 26778473
J Neurol Sci. 2016 Feb 15;361:243-9
pubmed: 26810550
Dtsch Arztebl Int. 2016 Feb 5;113(5):61-9
pubmed: 26900156
BMC Med Educ. 2016 Feb 25;16:70
pubmed: 26911194
Parkinsonism Relat Disord. 2016 Jul;28:100-6
pubmed: 27158122
Parkinsonism Relat Disord. 2016 Oct;31:104-109
pubmed: 27510647
Neurology. 2016 Sep 27;87(13):1375-83
pubmed: 27566741
Chest. 1989 Nov;96(5):1212-4
pubmed: 2805857
Parkinsonism Relat Disord. 2017 Nov;44:33-37
pubmed: 28847681
Curr Opin Otolaryngol Head Neck Surg. 2017 Dec;25(6):475-479
pubmed: 28937519
Neurology. 2018 Jan 9;90(2):74-82
pubmed: 29237794
Mov Disord. 2018 Mar;33(3):372-390
pubmed: 29508455
Neurodegener Dis. 2018;18(2-3):84-90
pubmed: 29621788
J Laryngol Otol. 1988 Mar;102(3):280-1
pubmed: 3356942
J Neurol Neurosurg Psychiatry. 1979 Feb;42(2):151-3
pubmed: 422962
Laryngoscope. 1984 Mar;94(3):348-53
pubmed: 6700351
Laryngoscope. 1984 Aug;94(8):1106-8
pubmed: 6748839
Ann Otol Rhinol Laryngol. 1983 Jan-Feb;92(1 Pt 1):85-90
pubmed: 6824289
J Neurol Neurosurg Psychiatry. 1981 Jan;44(1):49-53
pubmed: 7205305
Brain. 1981 Jun;104(2):351-68
pubmed: 7237099
Ann Otol Rhinol Laryngol. 1981 Sep-Oct;90(5 Pt 1):430-41
pubmed: 7305195
Brain. 1994 Aug;117 ( Pt 4):835-45
pubmed: 7922469
J Neurol Sci. 1995 Jun;130(2):197-202
pubmed: 8586986
J Voice. 1996 Dec;10(4):354-61
pubmed: 8943139
Neurology. 1997 Feb;48(2):384-93
pubmed: 9040727
J Neurol Neurosurg Psychiatry. 1997 Mar;62(3):234-8
pubmed: 9069477
Mov Disord. 1997 Mar;12(2):133-47
pubmed: 9087971
J Laryngol Otol. 1998 Feb;112(2):177-8
pubmed: 9578881

Auteurs

Tobias Warnecke (T)

Department of Neurology, University of Münster, Münster, Germany.

Annemarie Vogel (A)

Hospital for Movement Disorders/Parkinson's Disease, Beelitz-Heilstätten, Germany.

Sigrid Ahring (S)

Department of Neurology, University of Münster, Münster, Germany.

Doreen Gruber (D)

Hospital for Movement Disorders/Parkinson's Disease, Beelitz-Heilstätten, Germany.
Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany.

Hans-Jochen Heinze (HJ)

Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany.

Rainer Dziewas (R)

Department of Neurology, University of Münster, Münster, Germany.

Georg Ebersbach (G)

Hospital for Movement Disorders/Parkinson's Disease, Beelitz-Heilstätten, Germany.

Florin Gandor (F)

Hospital for Movement Disorders/Parkinson's Disease, Beelitz-Heilstätten, Germany.
Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany.

Classifications MeSH